Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Cash from Investing Activities (2018 - 2025)

X4 Pharmaceuticals' Cash from Investing Activities history spans 8 years, with the latest figure at $16.8 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 295.44% year-over-year to $16.8 million; the TTM value through Dec 2025 reached $8.2 million, down 87.83%, while the annual FY2025 figure was $8.2 million, 87.83% down from the prior year.
  • Cash from Investing Activities reached $16.8 million in Q4 2025 per XFOR's latest filing, up from -$28.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $96.9 million in Q2 2024 to a low of -$28.7 million in Q3 2025.
  • Average Cash from Investing Activities over 5 years is $3.0 million, with a median of -$62000.0 recorded in 2021.
  • The largest YoY upside for Cash from Investing Activities was 2083.25% in 2024 against a maximum downside of 59033.33% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$13000.0 in 2021, then crashed by 161.54% to -$34000.0 in 2022, then plummeted by 14114.71% to -$4.8 million in 2023, then plummeted by 78.38% to -$8.6 million in 2024, then surged by 295.44% to $16.8 million in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Cash from Investing Activities are $16.8 million (Q4 2025), -$28.7 million (Q3 2025), and $23.1 million (Q2 2025).